A rare cryptic translation product is presented by Kb major histocompatibility complex class I molecule to alloreactive T cells.
about
Unanticipated antigens: translation initiation at CUG with leucineThe mouse mammary tumor virus env gene is the source of a CD8+ T-cell-stimulating peptide presented by a major histocompatibility complex class I molecule in a murine thymoma.Identification of a CD4+ T cell-stimulating antigen of pathogenic bacteria by expression cloning.Ribosomal scanning past the primary initiation codon as a mechanism for expression of CTL epitopes encoded in alternative reading framesPeptide-independent recognition by alloreactive cytotoxic T lymphocytes (CTL).Initiation codon scanthrough versus termination codon readthrough demonstrates strong potential for major histocompatibility complex class I-restricted cryptic epitope expression.Protective immunity does not correlate with the hierarchy of virus-specific cytotoxic T cell responses to naturally processed peptides.Tumor antigens discovery: perspectives for cancer therapy.Allopeptides and the alloimmune response.Nowhere to hide: unconventional translation yields cryptic peptides for immune surveillanceViral infection causes a shift in the self peptide repertoire presented by human MHC class I molecules.Generation of cytotoxic T lymphocytes against immunorecessive epitopes after multiple immunizations with adenovirus vectors is dependent on haplotype.Recognition of allo-peptide is governed by novel anchor imposition and limited variations in TCR contact residues.Presentation of Cryptic Peptides by MHC Class I Is Enhanced by Inflammatory Stimuli.Alloreactivity, antigen recognition and T-cell selection: three diverse T-cell recognition problems with a common solution.Global proteogenomic analysis of human MHC class I-associated peptides derived from non-canonical reading frames.Brain dead donor kidneys are immunologically active: is intervention justified?CD4(+) CD25(+) FoxP3(+) regulatory T cells suppress cytotoxicity of CD8(+) effector T cells: implications for their capacity to limit inflammatory central nervous system damage at the parenchymal level.Alloreactive T cells respond specifically to multiple distinct peptide-MHC complexes.Direct quantitation of MHC-bound peptide epitopes by selected reaction monitoring
P2860
Q21146394-769F0113-41CA-4B52-B0E3-103CEA50321FQ35940447-706DF83C-71A3-44AC-8A69-CD53D512C701Q36365620-2A060707-CF4B-44D4-BB34-CDE6B59198B7Q36367448-2D37EB33-48EE-4612-97DB-32859060E0E0Q36377031-CD05840B-681A-4F7D-A888-38A33FE07283Q36380627-A059089C-F8DF-4231-9DC0-06F0C5631DCFQ36400848-53F2E226-B397-40AB-8040-9BE2E0C58E25Q36438078-FFBE03E1-695A-465A-9B70-796E10490E23Q37006610-7119DC24-CB9C-44B8-B70D-11AA134E8AB0Q37028320-F11E724A-D2BF-4D46-9194-216F63E4E19CQ37035972-A0BBDE19-2553-4AAB-8B61-22728DEEE9CDQ39878719-632011DE-EC7F-4B16-B3FA-4DD24F4461D4Q40057214-208EC7E5-143C-415B-B247-912C364E1058Q40534425-878BFD5E-BE2D-46D7-B9E5-18EEB56BBF0AQ41349742-A4F7D01B-095A-4EB5-B7FF-D6F83E348D58Q41906355-865117BA-1BA4-439B-95D5-E22624186EF7Q42142676-9185F49D-F462-4EDD-B06F-68904A8ACCF9Q42575046-51279F22-8C2B-4672-B3B9-4CBAEE81A83CQ42613015-F62C4835-9D22-4A4B-AD74-D721E639BCC8Q57053701-755FCDBC-3180-4457-8FFB-CA01B7FB8E15
P2860
A rare cryptic translation product is presented by Kb major histocompatibility complex class I molecule to alloreactive T cells.
description
1995 nî lūn-bûn
@nan
1995年の論文
@ja
1995年学术文章
@wuu
1995年学术文章
@zh-cn
1995年学术文章
@zh-hans
1995年学术文章
@zh-my
1995年学术文章
@zh-sg
1995年學術文章
@yue
1995年學術文章
@zh
1995年學術文章
@zh-hant
name
A rare cryptic translation pro ...... ecule to alloreactive T cells.
@ast
A rare cryptic translation pro ...... ecule to alloreactive T cells.
@en
type
label
A rare cryptic translation pro ...... ecule to alloreactive T cells.
@ast
A rare cryptic translation pro ...... ecule to alloreactive T cells.
@en
prefLabel
A rare cryptic translation pro ...... ecule to alloreactive T cells.
@ast
A rare cryptic translation pro ...... ecule to alloreactive T cells.
@en
P2093
P2860
P356
P1476
A rare cryptic translation pro ...... ecule to alloreactive T cells.
@en
P2093
Afkarian M
Malarkannan S
P2860
P304
P356
10.1084/JEM.182.6.1739
P407
P577
1995-12-01T00:00:00Z